Answers are grounded in this paper and cite their sources.
The study finds that modulating autophagy affects chemo-resistance in cancer cell lines, suggesting new therapeutic strategies.
Autophagy is not just a way to get rid of damaged, mutated, or genetically unstable cells, but it also increases the chances that tumor cells can overcome the effects of chemotherapy-induced damage. Anthracyclines have a cytoprotective effect of autophagy in most cancer cell lines. The blocking of autophagy in this case makes tumor cells more sensitive to therapy. Cytoprotective autophagy activation can cause chemoresistance, and if it is overstimulated, it can cause energy depletion and autophagic death. In some cases, cytotoxic autophagy develops under the action of anthracyclines and blocking it increases cell survival. On the contrary, activation of cytotoxic autophagy triggers the process of “self-eating”. Modulating autophagy can be a dual-edged sword for tumor cells, leading to both death and survival.
No takes yet. Share an insight, caveat, or question.
N. A. Persiyantseva (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: